Quebec Breast Cancer Foundation
8
3
3
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer
Role: collaborator
Targeted Axillary Dissection (TAD) in Early-stage Node Positive Breast Cancer
Role: collaborator
Pilot Study of PACHA Program to Enhance Adherence to Adjuvant Endocrine Therapy Among Breast Cancer Survivors
Role: collaborator
Breast Cancer Plasma Adjuvant Intra-operative Treatment (Breast Cancer PAINT)
Role: collaborator
Life After Breast Cancer - Impact of a Life Coach
Role: collaborator
Physical Activity Levels and Functional Improvement in Breast Cancer Survivors
Role: collaborator
Vitamin D and Mammographic Breast Density
Role: collaborator
Sentinel Node Biopsy Following NeoAdjuvant Chemotherapy in Biopsy Proven Node Positive Breast Cancer
Role: collaborator
All 8 trials loaded